Moderate levels of alcohol consumption linked to higher risk of some cancers, NCI writes in JAMA

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Even moderate levels of alcohol consumption appear to be associated with a higher risk of some cancers—including cancers of the female breast—as well as adverse cardiovascular health effects, NCI researchers wrote in JAMA.

The article, “Alcohol and Cancer: Research and Clinical Implications,” is co-authored by three associate directors in the Division of Cancer Control and Population Sciences at NCI.

The paper highlights the low awareness of the association between alcohol use and cancer and makes a call for increasing clinician knowledge and patient-provider communication regarding the effects of alcohol on cancer. The authors also supports increased focus and research on the harms of moderate drinking, in addition to the more commonly studied harms from risky drinking and alcohol use disorders.

Alcohol is associated with almost 90,000 cases of cancer of the oral cavity, throat, liver, female breast, and colorectum per year. Awareness of this relationship is low not only in the U.S., but worldwide. The paper also notes evidence that reductions in alcohol use are associated with decreased cancer mortality.

Table of Contents

YOU MAY BE INTERESTED IN

The long-awaited results from the RASolute 302 trial—a phase III clinical trial evaluating daraxonrasib, a RAS inhibitor, for the treatment of patients with previously treated, metastatic pancreatic ductal adenocarcinoma—have been read out. 
At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login